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Rationale: There is increasing interest in the potential influence of
fetal and early life conditions on childhood wheezing.
Objectives: To investigate the associations between maternal com-
plications and procedures in pregnancy and at birth and the risk
of various wheezing phenotypes in young children.
Methods: We studied 15,609 children, aged 6–7 yr, enrolled in a
population-based study. Standardized questionnaires were com-
pleted by the children’s mothers.
Results: Of the children, 9.5% (1,478) had transient early wheezing,
5.4% (884) had persistent wheezing, and 6.1% (948) had late-onset
wheezing. Maternal hypertension or preeclampsia was associated
with an increased risk of all three wheezing phenotypes (for tran-
sient early wheezing: odds ratio [OR], 1.40; 95% confidence interval
[95% CI], 1.08–1.82; for persistent wheezing: OR, 1.59; 95% CI,
1.15–2.19; and for late-onset wheezing: OR, 1.47; 95% CI, 1.06–
2.01). Use of antibiotics for urinary tract infections was associated
with transient early wheezing (OR, 1.52; 95% CI, 1.16–2.00),
whereas antibiotic administration at delivery was associated with
both transient early wheezing (OR, 1.21; 95% CI, 1.01–1.46) and
persistent wheezing (OR, 1.39; 95% CI, 1.10–1.75). Children who
had amother with diabetes were alsomore likely to have persistent
wheezing (OR, 1.72; 95% CI, 0.99–3.00). Neither amniocentesis/
chorionic villus sampling, nor weight gain in pregnancy, nor cesar-
ean section was associated with the subsequent development of
wheezing. Maternal asthma or atopy was not an effect modifier of
the associations found.
Conclusions: Some maternal complications during pregnancy and
at delivery may increase the risk of developing different phenotypes
of wheezing in childhood.
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Several studies have considered the possible role of pre- and
perinatal factors in the etiology of childhood wheezing and
asthma and in the early phenotypic expressions of these diseases
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AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Maternal smoking in pregnancy inﬂuences lung develop-
ment and is associated with wheezing in childhood; other
prenatal and perinatal factors (maternal infections, obstet-
ric conditions) have been inconclusively associated with
wheezing among offspring.
What This Study Adds to the Field
An association was found between maternal hypertension,
diabetes, and urinary tract infections during pregnancy and
exposure to antibiotics at delivery with wheezing disorders,
in particular wheezing of early onset.
(1). The most studied in utero environmental inﬂuence on lung
development is maternal smoking in pregnancy, which has been
shown to be associated not only with wheezing in childhood
(2–5) but also with a dose-related reduction in lung function
in the newborn period. Fetal development seems therefore to
represent a critical time of pulmonary vulnerability with respect
to smoking exposure. More recently, some studies have also
investigated the relationships between exposure to maternal in-
fections in pregnancy (6–8), maternal obstetric conditions (hyp-
eremesis, hypertension, and preeclampsia) (9–11), uterine fac-
tors (antepartum hemorrhage, preterm contractions, placental
insufﬁciency, and uterine growth restriction) (9–11), malposition
or malpresentation of the fetus (11), mode of delivery (11–18),
and the development of asthma among offspring. However, the
ﬁndings of these studies have been inconsistent.
In a report published in 1999 (19), we found associations
between a number of pre-, peri-, and early postnatal factors
and different wheezing phenotypes in a large multicenter cross-
sectional population-based study, the SIDRIA (Italian Studies
of Respiratory Disorders in Childhood and the Environment)
phase 1 study, an extension of the International Study onAsthma
and Allergies in Childhood (ISAAC) phase 1 study (20). The
enrolled children were categorized, on the basis of criteria de-
rived from Martinez and coworkers (21), as transient early
wheezers (children with wheezing in the ﬁrst 2 yr of life but not
at school age), persistent wheezers (children who continued to
wheeze at school age), late-onset wheezers (children who did
not wheeze in the ﬁrst years of life but who wheezed when 6–7 yr
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old), or nonwheezers (all other children). In that study we
focused on the importance of early life factors on the subsequent
manifestation of wheezing, and we reported the associations of
various exposures with the different wheezing phenotypes.
A second phase of the SIDRIA study was conducted in 2002
in 12 centers in northern, central, and southern Italy to evaluate
possible time changes in the prevalence of respiratory disorders
in childhood (22), to conﬁrm the role of potential risk factors
identiﬁed in SIDRIA-1 (23) and to investigate new risk factors.
In this article we evaluate the associations between maternal
medical complications and procedures during pregnancy and at
delivery, and the risks of the various wheezing phenotypes in
young children.
The preliminary results of these analyses have been pre-
viously reported in the form of an abstract (24).
METHODS
The full details of the SIDRIA study have been reported elsewhere (23,
25), and are described in the online supplement. The current analysis is
based on the data for 6- to 7-yr-old children whose questionnaires were
completed by their biological mothers alone or together with their
fathers. Three mutually exclusive outcomes were included in the analy-
sis: (1 ) those who had at least one lower respiratory tract illness with
wheezing (bronchiolitis or asthmatic bronchitis or asthma or wheezing)
in the ﬁrst 2 yr of life, and had no wheezing in the last 12 mo (transient
early wheezers); (2 ) those who had at least one lower respiratory tract
illness with wheezing in the ﬁrst 2 yr of life, and had wheezing in the
last 12mo (persistent wheezers); and (3 ) those with no lower respiratory
tract illness with wheezing in the ﬁrst 2 yr of life but who had wheezing
in the last 12 mo (late-onset wheezers). The remainder comprised those
with no lower respiratory tract illness with wheezing in the ﬁrst 2 yr of
life, no asthma up to 6 to 7 yr, and no wheezing in the last 12 mo
(nonwheezers). Children for whom data on respiratory diseases in the
ﬁrst 2 yr of life or on wheezing symptoms in the last 12 mo were lacking
were excluded from the analysis.
A number of maternal medical complications or procedures during
pregnancy and at birth were examined: amniocentesis or chorionic
villus sampling, hypertension requiring therapy, preeclampsia, diabetes
before or during pregnancy, use of antibiotics for urinary tract infections
and for respiratory infections, gestational weight gain classiﬁed as low
(less than 9 kg) or high (greater than 15 kg), use of antibiotics at
delivery, and cesarean section.
The following potential confounders were identiﬁed a priori: study
center, parental history of asthma or atopy, maternal smoking in preg-
nancy, sex of the child, low birth weight (less than 2,500 g), siblings,
maternal age at birth, socioeconomic status (parental schooling, mold
or damp in child’s bedroom during his ﬁrst year of life), season of
the questionnaire’s completion, and the person who completed the
questionnaire (i.e., the mother alone or together with father).
Missing values were considered as negative responses when frequen-
cies were computed. The proportion with missing values was lower
than 7% for each question. The associations betweenmaternal variables
and each group of wheezing children (taking as reference group those
withoutwheezing)were assessed by polytomous logistic regression anal-
ysis (26), which allows to assess simultaneously the effects of various
factors on three mutually exclusive outcomes. Odds ratios (ORs) were
ﬁrst adjusted only for the potential confounders reported above. Subse-
quently, we also included the maternal complications and procedures
in the multivariate analysis. All the regression models have been per-
formed on the dataset of children with no missing answers to any of
the maternal variables or confounders (the complete dataset).
Possible effect modiﬁcation by maternal history of asthma or allergy
was evaluated by introducing interaction terms into the regression mod-
els. Birth weight may be an intermediate factor in the causal pathway
betweenmaternal complications and wheezing; therefore we also tested
the association between maternal variables and wheezing excluding
childrenwith a birth weight of less than 2,500 g. Finally, in the evaluation
of the role of cesarean section, to control for circumstances that could
lead to a decision in favor of instrumental delivery, we also conducted
an analysis excluding children who fulﬁlled any of the following criteria:
birth weight less than 2,500 g or greater than 5,000 g, multiple births,
or premature delivery (gestational age less than 37 wk).
To evaluate the robustness of our results to alternative modeling
choices, we conducted a sensitivity analysis using a “propensity score”
approach (27) as described in the online supplement. The propensity
score approach attempts to control for confounding in nonexperimental
studies by adjusting for the likelihood that a given subject is exposed.
It is used when several explanatory variables are likely to be correlated,
as in the case of maternal complications and procedures, and when
investigators have no control on the experimental plan of the study as
in the case of observational studies, which may increase the risk of
selection bias.
Statistical analyses were performed with Stata 8 (StataCorp, College
Station, TX).
RESULTS
Questionnaires were returned for 20,016 children (response rate,
89.2%). Questionnaires were completed by the father only, or by
a person different from the biological mother, for 1,695 children.
Complete data for respiratory diseases in the ﬁrst 2 yr of life
and for wheezing symptoms in the last 12 mo were not available
for 2,712 children, leaving a total of 15,609 children (8,003 males
and 7,606 females) for the present analysis. The children not
included in the analysis differed from those who were included
in their lower degree of parental education (university, 19.2%
in those not included and 22.6% in those included; high school,
42.6% in those not included and 48.7% in those included; p 
0.0001). The principal characteristics of the children studied are
shown inTable 1. Of these, 9.5% (1,478) were classiﬁed as having
had transient early wheezing, 5.4% (844) as having had persistent
wheezing, and 6.1% (948) as having had late-onset wheezing,
whereas 79% (12,339) were “nonwheezers.”
Table 2 shows, for the three wheezing phenotypes and for
children without any wheezing history, the frequencies of expo-
sure and the association with maternal medical complications
and procedures adjusted for the set of potential confounding
factors deﬁned a priori. A borderline statistically signiﬁcant asso-
ciation was found between amniocentesis or chorionic villus
sampling and transient early wheezing. Among maternal health
complications during pregnancy, hypertension or preeclampsia
was associated with an increased risk of all three wheezing out-
comes, whereas prescription of antibiotics for urinary tract infec-
tions, and antibiotics administered at delivery, were associated
only with early-onset wheezing (including both transient and
persistent wheezing). Prescription of antibiotics for respiratory
infections was strongly associated with persistent and late-onset
wheezing. Maternal diabetes was associated with persistent
wheezing. Children born by cesarean section had no increased
TABLE 1. CHARACTERISTICS OF STUDY PARTICIPANTS
Children Studied
Characteristic (n  15,609)
Age, yr (mean  SD) 6.7  0.64
Male sex, n (%) 8,003 (51.2)
Parental history of asthma, n (%) 1,975 (12.7)
Parental history of atopy, n (%) 6,201 (39.7)
Maternal smoking in pregnancy, n (%) 1,809 (11.6)
Low birth weight ( 2,500 g), n (%) 945 (6.1)
Parental schooling
University, n (%) 3,521 (22.6)
High school (13 yr), n (%) 7,609 (48.7)
 13 yr, n (%) 4,439 (28.4)
Maternal age at birth, mean  SD 30.9  4.9
Mold or damp in child’s bedroom during the first year of 1,969 (12.6)
life, n (%)
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TABLE 2. ASSOCIATIONS OF MATERNAL COMPLICATIONS OR PROCEDURES DURING
PREGNANCY AND AT BIRTH WITH VARIOUS TYPES OF WHEEZING IN YOUNG CHILDREN
Transient Early Persistent Late-Onset
Nonwheezers Wheezing Wheezing Wheezing
Maternal Complications or Procedures (n  12,339) (n  1,478) (n  844) (n  948)
Amniocentesis or chorionic villus sampling
Frequency, % 18.5 19.6 17.8 18.6
OR (95% CI) 1.19 (1.00–1.42) 0.98 (0.77–1.24) 1.08 (0.87–1.34)
Hypertension or preeclampsia
Frequency, % 5.2 7.4 7.6 6.9
OR (95% CI) 1.47 (1.14–1.89) 1.71 (1.25–2.36) 1.45 (1.06–1.48)
Diabetes
Frequency, % 1.5 2 2 1.8
OR (95% CI) 1.39 (0.87–2.23) 1.84 (1.06–3.20) 0.97 (0.49–1.91)
Antibiotics for urinary tract infections in pregnancy
Frequency, % 3.8 5.8 5.7 5
OR (95% CI) 1.57 (1.20–2.06) 1.31 (0.89–1.91) 1.13 (0.77–1.65)
Antibiotics for respiratory infections in pregnancy
Frequency, % 1.8 2.8 4.3 3.0
OR (95% CI) 0.99 (0.54–1.83) 2.91 (1.73–4.86) 2.25 (1.32–3.83)
Weight gain  9 kg
Frequency, % 13.8 13.6 14 14.1
OR (95% CI) 1.00 (0.83–1.22) 1.09 (0.85–1.40) 1.12 (0.89–1.40)
Weight gain  15 kg
Frequency, % 18.1 21 21.8 17.8
OR (95% CI) 1.14 (0.97–1.34) 1.23 (0.85–1.40) 0.94 (0.76–1.40)
Antibiotics at delivery
Frequency, % 12.9 16.1 18.6 14.6
OR (95% CI) 1.25 (1.05–1.48) 1.44 (1.17–1.79) 1.04 (0.83–1.29)
Cesarean section
Frequency, % 26.5 27.3 29.3 25.6
OR (95% CI) 1.04 (0.90–1.20) 1.12 (0.93–1.36) 0.99 (0.83–1.19)
Definition of abbreviations: CI  confidence interval; OR  odds ratio.
The ORs were estimated with polytomous logistic regression including as confounders: study center, parental history of asthma
or atopy, maternal smoking in pregnancy, maternal age at birth, sex, low birth weight, siblings, socioeconomic status (parental
schooling, mold or damp in child’s bedroom during his first year of life), season of the questionnaire’s completion, and person
who completed the questionnaire. The logistic regression analyses have been performed on the complete dataset (no missing
answers to any of the variables), including the following: nonwheezers  9,740; transient early wheezing  1,124; persistent
wheezing  611; late-onset wheezing  712.
risk ofwheezing, not evenwhen childrenwith conditions possibly
related to instrumental delivery (6.2% of the whole sample)
were excluded from the analysis.
The associations between various maternal complications and
procedures and the wheezing outcomes, mutually adjusted by
logistic regression analysis, are shown in Table 3. In this analysis
TABLE 3. ASSOCIATIONS OF MATERNAL COMPLICATIONS OR PROCEDURES DURING
PREGNANCY AND AT BIRTH WITH WHEEZING IN YOUNG CHILDREN IN REGRESSION
ANALYSIS WITH MUTUAL ADJUSTMENT
Transient Early Persistent Late-Onset
Maternal Complications or Procedures Wheezing Wheezing Wheezing
Amniocentesis or chorionic villus sampling 1.19 (1.00–1.43) 0.97 (0.76–1.23) 1.07 (0.87–1.34)
Hypertension or preeclampsia 1.40 (1.08–1.82) 1.59 (1.15–2.19) 1.47 (1.06–2.01)
Diabetes 1.33 (0.83–2.14) 1.72 (0.99–3.00) 0.94 (0.47–1.86)
Antibiotics for urinary tract infections in pregnancy 1.52 (1.16–2.00) 1.21 (0.83–1.79) 1.12 (0.76–1.64)
Weight gain:
 9 kg 1.00 (0.82–1.21) 1.08 (0.84–1.39) 1.11 (0.89–1.40)
 15 kg 1.12 (0.96–1.31) 1.20 (0.98–1.48) 0.93 (0.75–1.14)
Antibiotics at delivery 1.21 (1.01–1.46) 1.39 (1.10–1.75) 1.03 (0.81–1.30)
Cesarean section 0.95 (0.81–1.11) 0.97 (0.78–1.19) 0.96 (0.79–1.17)
Reference group: nonwheezers. Values represent odds ratios, with 95% confidence intervals shown in parentheses. The odds
ratios were estimated with polytomous logistic regression, including the variables shown in addition to all the following variables:
study center, parental history of asthma or atopy, maternal smoking in pregnancy, maternal age at birth, sex, low birth weight,
siblings, socioeconomic status (parental schooling, mold or damp in child’s bedroom during his first year of life), season of the
questionnaire’s completion, person who completed the questionnaire. The logistic regression analysis has been performed on the
complete dataset (no missing answers to any of the variables), including the following: nonwheezers  9,740; transient early
wheezing  1,124; persistent wheezing  611; late-onset wheezing  712.
we decided not to include in the multivariate model the adminis-
tration of antibiotics for respiratory infections in pregnancy,
which, in the previous model, was strongly associated with an
increased risk of persistent and late-onset wheezing. In fact,
motherswith a diagnosis of asthmaweremore likely to be treated
during pregnancy with antibiotics for respiratory infections
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(4.7%, in comparison with 1.9% of mothers without a diagnosis
of asthma), and we were concerned that this could affect the
association with wheezing in the offspring. As in the previous
analysis (Table 2), maternal hypertension or preeclampsia was
associated with all the wheezing phenotypes, antibiotics adminis-
tered during pregnancy for urinary tract infections were associated
only with transient early wheezing, and antibiotics administered
at delivery were associated with both transient and persistent
wheezing (Table 3). There was a borderline statistically signiﬁ-
cant association (OR, 1.72; 95%CI, 0.99–3.00) betweenmaternal
diabetes before and/or during pregnancy and persistent wheez-
ing; the wide conﬁdence interval observed is due to the low
number of women affected by this condition. Children of low
birth weight were not more likely to wheeze than children with
a birth weight of at least 2,500 g and the OR (95% CI) values
were 1.05 (0.81–1.38), 0.96 (0.67–1.39), and 0.71 (0.49–1.05) for
transient early wheezing, persistent wheezing, and late-onset
wheezing, respectively. As a consequence, the strength and the
direction of associations between the various maternal variables
and different wheezing phenotypes did not change when we
excluded from the analysis children of low birth weight.
A maternal history of asthma and/or atopy did not modify
the association betweenmaternal complications or procedures in
pregnancy and at birth andwheezing phenotypes. No association
with cesarean section was found after the exclusion of conditions
possibly related to instrumental delivery. Finally, the propensity
score analysis (results presented in the online supplement)
yielded results similar to those obtained by multiple logistic
regression, which are reported in Table 3.
DISCUSSION
The ﬁndings of the present study suggest thatmaternal complica-
tions during pregnancy and at birth may be associated with the
development of wheezing disorders in young children. If these
ﬁndings are causal, they are generally consistent with the concept
of “programming,” which occurs when an event in a critical early
period of an organism’s life permanently changes its structure
or function. This hypothesis has received extensive interest on
the basis of accumulating evidence of a relationship between
early life environmental factors and a wide range of chronic
diseases, particularly hypertension and diabetes (28, 29), but
also, although less conclusively, obstructive lung disease (30–32).
The greater inﬂuence of maternal compared with paternal
asthma and atopy on the development of asthma in offspring
suggests that the pre- and perinatal environment also plays a
role in the subsequent development of respiratory disease in
children (19, 33).
In the present study we identiﬁed three maternal health com-
plications during pregnancy as risk factors for wheezing in child-
hood: hypertension requiring therapy during pregnancy or pre-
eclampsia, diabetes, and urinary tract infections treated with
antibiotics. Whereas the ﬁrst factor was associated with all three
wheezing phenotypes, the other two were risk factors only for
persistent wheezing and transient early wheezing, respectively.
The relationship between maternal hypertension in pregnancy
and asthma development in the offspring has, to our knowledge,
previously been investigated in only one study (11). This was a
retrospective study of a cohort of 4,065 children and adolescents
aged 1 to 18 yr, and it did not ﬁnd an associationwith an increased
lifetime asthma risk. Our ﬁndings suggest that abnormalities in
the fetal placental circulation occurring in hypertensive pregnan-
cies, as well as in diabetic pregnancies (34, 35), may result in
fetal airway damage. Another possible explanation is that hyper-
tension in pregnancy may result in fetal growth restriction and
hence in diminished airway function (36). In diabetic pregnan-
cies, a delay in the production of phosphatidylglycerol and hence
a surfactant deﬁciency, together with an increased susceptibility
to respiratory distress syndrome, could also account for the ex-
cess risk of persistent wheezing in infants (37).
The role of maternal infections in pregnancy in the develop-
ment of asthma has been explored in three cohort studies in
Denmark (8), Finland (6), and the United Kingdom (7). In the
ﬁrst study (8), antibiotic use in pregnancy was not associated
with hospital admission for asthma or wheezing bronchitis in
the ﬁrst 3 yr of life in the offspring, whereas an association was
found with antiasthma medication during the ﬁfth year of life.
In the study conducted by Xu and coworkers (6), children had
a higher risk of asthma by age 7 yr if their mothers experienced
vaginitis and febrile infections during pregnancy. McKeever and
coworkers (7) suggested that exposure to antibiotics or infection
in utero is associated with an increased dose-related risk of
asthma and wheezing, as well of eczema and hay fever; chil-
dren who had experienced these exposures had an early age of
onset of asthma or wheeze (mean, 1.6 yr). In that study, a high
percentage of mothers, approximately one-third, were pre-
scribed one or more courses of antibiotics during pregnancy,
most commonly for respiratory tract infections. We were con-
cerned that respiratory infections treated with antibiotics may
indicate a predisposition for asthma in the mother, and also
that in a retrospective study mothers may preferentially recall
respiratory problems if their children developed wheezing. Thus
in the ﬁnal analysis we chose to focus on urinary tract infections
treated with antibiotics. Urinary tract infections in pregnancy
are believed to be a marker of abnormal colonization of the
genitourinary tract and to predispose women to chorioamnionitis
(38, 39). A possible explanation for our ﬁndings may be that
antenatal infections or inﬂammation associatedwith chorioamni-
onitis could modulate lung development and injury (40). Alter-
natively, as discussed by other investigators, antibiotics can cross
the placenta and enter the fetal circulation or can modify mater-
nal microbial load during pregnancy (7), and have an effect
on infant gut colonization and hence on the maturation and
differentiation of the mucosal immune system (41, 42). This may
also explain the small increase in risk of early-onset wheezing
we found in children of mothers who received antibiotics at
delivery.
We found no evidence that cesarean section, which also has
been reported to have an impact on gut colonization (43), is
associated with an increasing risk of developing wheezing. Previ-
ous studies (11–18) of this issue have produced inconsistent
results. There are a number of methodologic issues that should
be evaluated when considering the association between asthma
and cesarean birth: criteria for selection of the study population
(i.e., exclusion or inclusion of premature or low birth weight
infants), controlling for factors associated with cesarean delivery
(i.e., prematurity, maternal obesity, maternal asthma, and social
class), variations in the ratio of emergency and elective cesarean
section in different regions, as well as duration of follow-up.
The issue warrants further research, particularly in light of the
continually increasing rate of cesarean section in many countries
(44).
Maternal asthma or atopy was not an effect modiﬁer of the
associations found, that is, the degree of association between
maternal complications or procedures in pregnancy and wheez-
ing was similar among children whose mothers had a positive
history of asthma or atopy and children of mothers with a nega-
tive history. This does not mean that maternal asthma or atopy
does not increase the risk of asthma in the child; rather it means
that the effect of maternal asthma or atopy does not modify the
effects of maternal complications and procedures in pregnancy.
20 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 175 2007
Our study was population based and included a large group
of subjects to ensure adequate statistical power. To assess the
independent role of early life factors in the development of
wheezing, we adjusted for a large number of factors that could
predispose to childhood asthma. However, we were not able to
control for additional confounders (e.g., prenatal exposure to
air pollution other than passive smoking [45] or paracetamol
use in pregnancy [46]), or to take into account other possible
maternal complications in pregnancy (e.g., premature rupture
of the membranes) and the impact of intrauterine growth
retardation.
In performing themultivariate analysis, we realized that some
of the variables were somehow correlated, for example, cesarean
section and antibiotics at delivery, preeclampsia and low birth
weight, and amniocentesis or chorionic villous sampling and ma-
ternal age, with the possibility of underestimating the risk because
of overadjustment. The propensity score approach, however,
yielded similar results when compared with the more traditional
approach we adopted.
The retrospective design of the study raises a number of
issues, including the validity of a questionnaire that asks mothers
to recall events that occurred 7 to 8 yr in the past. The validity
of some itemswas evaluated in a pilot study in one center (Trento
Province) in which administrative data collected at birth were
available (results are reported in the online supplement). Other
studies have suggested reasonable reliability and validity for
long-term maternal recall of events and medical complications
during pregnancy, labor, or delivery (47, 48). Mothers may recall
more accurately events that they believe are especially relevant,
such as amniocentesis or cesarean section, or that they have
previously noted at gynecologic visits during pregnancy or at
admission to hospital, such as hypertension or diabetes or infec-
tions during pregnancy. However, such selective recall would
produce signiﬁcant bias only if over (or under) reporting of
such exposures was different between mothers of children with
wheezing and those of nonwheezers. This seems unlikely for
pregnancy complications, particularly because the participants
were not given any information about their possible associations
with wheezing in their offspring.
The retrospective design of the study could have resulted
in a reduced recall of milder wheezing symptoms. To increase
speciﬁcity, particularly for wheezing in the ﬁrst 2 yr of life, we
asked parents to report episodes of bronchiolitis or asthmatic
bronchitis in addition to wheezing. Our estimated prevalence of
wheeze in the ﬁrst 6 yr of life is lower than that reported in
the prospective Tucson Children’s Respiratory Cohort Study by
Martinez and coworkers (21), and in a retrospective survey in
Leicester in the United Kingdom (49). This is in line with the
ISAACphase 1 ﬁndings, which showed thatwheezing prevalence
in school-age children and adolescents in Italy is considerably
lower than that in the United States, New Zealand, and the
United Kingdom, and also lower than that in most other non–
English-speaking European countries (20). Regarding misclassi-
ﬁcation of children with different wheezing phenotypes and of
nonwheezers, we may have included in the nonwheezer group
or in the late-onset wheezer group a number of children who
had milder symptoms in the ﬁrst 2 yr of life, or we may have
missed mild symptoms occurring in the 12 mo preceding the
questionnaire completion. However, such misclassiﬁcation is
likely to have been nondifferential (i.e., unrelated to exposure)
and would therefore have biased the ORs toward the null value
(50).
In conclusion, intrauterine factors other than maternal smok-
ing in pregnancy have been suggested to play a role in different
populations and settings in the development of wheezing and
asthma. Our ﬁndings suggest that maternal hypertension, diabe-
tes, and urinary tract infections during pregnancy and exposure
to antibiotics at delivery are potential risk factors for the devel-
opment of different wheezing disorders, in particular for wheez-
ing of early onset, a pattern of wheezing associated with congeni-
tal impairment of airway function (51, 52).
Our work was intended mainly to generate hypotheses re-
garding potential mechanisms occurring in pregnancy and
around the timeof birth, such as effects on the structural develop-
ment of the fetal lung and on the maturation of the infant im-
mune system. This gives suggestions for future prospective in-
vestigations to conﬁrm the ﬁndings and to explore possible
biological mechanisms and the different contribution of risk
factors to different wheezing conditions, particularly early-onset
wheezing.
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